Showing posts with label seminar. Show all posts
Showing posts with label seminar. Show all posts

Saturday, January 12, 2013

AAEP Annual Convention Set for end of Year: Time to Start Writing: Deadline is march 15, 2013

Call For Papers
59th AAEP Annual Convention
Nashville, Tennessee
December 7-11, 2013
Members of the American Association of Equine Practitioners and other individuals are invited to submit scientific papers, “how to” papers, and review papers for consideration for presentation during the 59th AAEP Annual Convention in Nashville, Tennessee, December 7-11, 2013.

To submit a paper, go to 
 http://aaep2013.abstractcentral.com. All papers must be submitted online by March 15, 2013, 3:00 p.m. ET and adhere to the Instructions for Authors.

A few key points:
1. Products and equipment must be identified by chemical or generic names or descriptions and footnoted.
2. Due to the length and complexity of the process, all deadlines are strictly enforced. 
3. Submission of a paper represents a commitment to present this paper at the meeting if it is selected.
4. Selected scientific papers, “how to” papers, and review papers will be printed in the 2013 AAEP Proceedings and presented at the 2013 Annual Convention. The presenting author will receive complimentary registration and a travel allowance.

Ethical Considerations: 
1. Authors are expected to disclose the nature of any financial interests they have with companies that manufacture or sell products that figure prominently in the submitted paper or with companies that manufacture or sell competing products. (This includes ownership, employment, consultancy arrangements, or service as an officer or board member.)
2. If your presentation references the use of a compounded pharmaceutical, please be certain that you are familiar with the FDA guidelines on the use of compounded pharmaceuticals and that the product you reference is in compliance.

Tuesday, January 8, 2013

Food and Drug Institute Compounding Dialogue


February 12, 2013

Program Description

Join FDLI for our upcoming program—Pharmacy Compounding: An FDLI Dialogue—on February 12 in Washington, DC. In an open, balanced format, experts will discuss and debate the regulation of pharmacy compounding, providing a historical framework and exploring recent developments. Participants will delve into key questions about policy, surveillance and enforcement, legislative and oversight issues. Discussion will address unresolved questions related to defining "compounding" and "manufacturing", as well as how the courts and Congress have interpreted FDA’s authority and role in regulating pharmacy compounding. With newly proposed legislation, the courts split, and statutory authority at issue, this is the ideal time for stakeholders to convene, communicate, and look ahead to what is next.

More information can be found here

Monday, September 17, 2012

Auburn University College of Veterinary Medicine Hosting Veterinary Pharmacy Law Seminar


Pharmacy Law Review

  • Veterinary Pharmacy Law
  • Continuing Education
  • For Veterinarians and Veterinary Technicians
  • Sunday, September 23, 2012
  • 1 p.m. to 3 p.m.
  • Overton Educational Wing
  • Auburn University College of Veterinary Medicine
Approved by the Florida and Alabama board for the law/pharmacology continuing education credit.

THIS 2-HOUR COURSE:

  • Explains current U.S. Drug Enforcement Administration laws for purchasing, documentation, dispensing, and storage and disposal of outdated controlled substances used in veterinary medical practices.
  • Describes in detail the current compounding regulations and extra-label use of medications that are laws through the U.S. Food and Drug Administration.
  • Explains devices, policies, and procedures for documentation of training and guidelines for occupational employee safety are included.

COURSE EXPERTISE

The course is taught by Sue Duran and Starr Miller who have a combined instruction training experience of 60 years in the area of veterinary pharmacy. Dr. Duran and Ms. Miller are diplomates of the International College of Veterinary Pharmacy (ICVP), an international college of experts who teach and dispense at veterinary teaching hospitals.

STATE-OF-THE-ART SETTING

Veterinarians and technicians can receive credit while experiencing the most up-to-date in learning. Veterinary Pharmacy Law takes place in the Overton Educational Wing, the college’s newest addition which features theatre-style lecture rooms and the latest in technology.

REGISTRATION

FEES

Veterinarians: $250
  • Early Bird Discounted Price:
  • $175 (by August 5)
  • $200 (by September 7)

TRAVEL INFORMATION

Auburn is serviced by Hartsfield-Jackson Atlanta International Airport. Travel to Auburn is available by rental car (approximately 90 minutes via I-85 South) or by shuttle (Express 85: 888-238-7738. Reservations are required.).
Auburn is in the CENTRAL time zone.
Atlanta is in the EASTERN time zone.
Visit our Web site at vetmed.auburn.edu/ce for directions, maps, and links to area accommodations.

QUESTIONS?

  • Contact Kris Robertson Street
  • 334-844-2497 or kris.street@auburn.edu 

Saturday, September 1, 2012

The New Texas Health Care Privacy Law (HB 300) and HIPAA/HITECH Compliance: What You Need To Know Now




Summary
This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians. This program has been approved for 1.0 contact hours of continuing education credit (0.1 CEUs). 

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE number 0154-0000-12-012-L03 and is accredited for 1.0 Contact Hours (0.1 CEUs). 

Description: This program will cover existing Texas privacy laws and information on the new legislation. 

At the completion of this program, pharmacists and technicians will be able to:
  • Identify the key components and requirements of HIPAA and the new Texas health care privacy law for Texas pharmacists, pharmacy technicians, pharmacies and other Texas entities.
  • Appraise the significance of pharmacy accountability and potential enforcement, audit, and civil penalty consequences for privacy breaches.
  • Comply with federal and state privacy and security laws, regulations and rules for the protection of identifiable protected health information.
For more information on this seiminar click here.

Texas Pharmacy Association Pharmacy Law Symposium

Texas Pharmacy Association 
presents: 
Texas Pharmacy Law Symposium

This program is for pharmacists.
This program is aimed at giving pharmacy professionals a better understanding of Texas and Federal drug laws. Students & reciprocating pharmacists should take this program to prepare for the state law exam.
When:Saturday - February 16, 2013
Where: Texas Association of School Boards (TASB) Building, 12007 Research Blvd., Austin, TX 78759
CLICK HERE to view a list of area hotels. 

If you need to take the course prior to this date, click here to view TPA's online Texas Pharmacy Law Symposium.
Learning Objectives: 
Upon completion of this program, participant will be able to:
    1. Identify the major provisions of the federal Food, Drug and Cosmetic Act that relate to the practice of pharmacy.
    2. Compare and contrast the requirements of the federal Controlled Substances Act and the Texas Controlled Substances Act.  
    3. Distinguish between dispensing and distribution of controlled substances and the record-keeping requirements for each.
    4. Describe the legal requirements for dispensing prescriptions for controlled substances, dangerous drugs and non-prescription medicines. 
    5.  Explain the Texas Drug Product Substitution Act.
    6. Explain the requirements for pharmacist and pharmacy licenses in Texas.
     
Agenda:
  8:00 a.m. – 12:00 p.m.:    Law Review program
12:00 p.m. –   1:00 p.m.:    Lunch break
  1:00 p.m. –   5:30 p.m.:    Law Review program / Q&A
 
For more information, click here.

Oklahoma Pharmacy Association 2012 Law Seminar

2012 OPhA Law Seminar

Please join us for our annual 2012 Law Seminar to be held on Sunday, December the 2nd from 8:00 am - 5:00pm at the OU College of Pharmacy in Oklahoma City. This program is intended for pharmacists, regardless of their practice setting who wish to increase and enhance their knowledge and skills as they relate to their knowledge of Oklahoma law. Our guest speakers include professionals from an array of law related backgrounds. I believe you'll find this eight hour program greatly informative. 
 
For more information cleck here.

Friday, August 31, 2012

More Great Training on Compounding for Veterinarians

Gigi Davidson will be presenting Compounding:  Pearls and Perils: 2012 Update, What Your Pharmacist Doesn't Know About Filling Prescriptions for Animals, and Right Bug, Right Drug: Maximizing Safety and Efficacy of Antibiotic Administration at the 2012 17th Annual North Carolina Veterinary Conference November 2-4, 2012.

For more information on this conference click here.

Upcoming CE Regarding best Practices for Prescribing and Obtaining Compounds

Upcoming CE at KIAWAH ISLAND RESORT in SC on September 7-9,2012.  Part of the CE includes Gigi Davidson, RPH, DIVCP presenting topics on Compounding:


New Drugs and New Ideas for Old or Unavailable Drugs: Finding Alternatives During Drug Shortages, New Uses for Old Drugs, New FDA Approvals
Best Practices for Prescribing and Obtaining Compounds: Protect Yourself and Your Patients-Checklist for Vetting Compounding Pharmacies, Compound Marketplace--What's Legal and What's Not, Simple Tools for Assessing the Quality of Compounds
Drug Interactions: Which Ones Really Matter? Basic Primer on Drug Interactions in Animals vs. Humans, Significant Drug Interactions for Top 50 Veterinary Drugs, Recognizing the "Rare" Drug Interaction When it Happens in Your Patient
 
For more information click here.
 
 
 
 
 
 
 
 
 
 

 

Sunday, August 19, 2012

ASPL Pharmacy Law Track and Annual Business Meeting

is scheduled for March 1-4, 2013, in Los Angeles, California. Save the date. More information can be found here.

2012 Developments in Pharmacy Law Seminar XXIII

The American Society for Pharmacy Law in conjunction with the National Alliance of State
Pharmacy Associations will host the 2012 Developments in Pharmacy Law Seminar XXIII on November 15-18, 2012,  at the Ventana Canyon Resort - Tucson, Arizona.  The current CE offered includes specific information regarding human and veterinary compounding laws:

8:15 am -  9:15 am 2012 Regulatory Enforcement Update
This past year has seen new and bold actions by law enforcement and
regulators to challenge the practices of pharmacies.  The prescription
drug abuse problem continues to cast a pall on the legitimate practice
of pharmacy, and the federal government, through the DEA and FDA,
have stepped up regulatory enforcement actions at pharmacies.  It will
be the aim of this presentation to review these legal developments
and to provide guidance regarding measures that can be undertaken
by pharmacies and their counsel to protect the pharmacy and offset
the actions of the regulators. 
William E. Fassett, PhD, RPh, Washington State University College of
Pharmacy; Ronald Friedman, JD, Lane Powell (1 credit hour)
9:15am – 10:15 am Developments in Controlled Substances
Regulation and a Foggy Crystal Ball
This presentation will provide additional details about the history of
DEA regulatory interpretation and reaction to judicial decisions, the
rationale for DEA enforcement actions, and some predictions about
the future directions for DEA rule-making and enforcement. 
D. Linden Barber, JD; Larry P. Cote, JD, Quarles & Brady LLP (1 credit
hour)
10:15 am – 10.30 am Break
10:30 am – 12:00 pm Social Media Land Mines for Pharmacists
The growth of social media has challenged attorneys to apply
traditional legal principals to new technology.  This program will briefly
describe the various forms of social media and explain application
of legal principals related to defamation, privacy, trade secret,
employment, the litigation process, and attorney ethics to the still
evolving world of social media. 
Randy Dryer, JD, Parsons, Behle & Latimer (1.5 credit hours)
12:00 pm – 1:00 pm Lunch - ASPL
1:00 pm –  3:00 pm Case Law Update
Again this past twelve months, courts, including the U.S. Supreme
Court, have made far reaching decisions that will impact pharmacies,
pharmacists, and the pharmaceutical industry.  This annual
presentation will discuss the Supreme Court’s decisions to uphold
PPACA, as well as court decisions that address the scope of pharmacists’
duty to warn, the reach of the DEA authority, employee and employer
rights, privacy and patient communications, conscientious objection
sanctions, and other topics. 
Roger Morris, RPh, JD, Quarles & Brady LLP; William J. Stilling, RPh, JD,
Parsons Behle & Latimer (2 credit hours)
3:15 pm – 4:45 pm HIPAA and HITECH: More Privacy and
Security Regulations and Their Impact on Pharmacy Compliance,
Patient Counseling, and Law Firms
The passage of the Health Information Technology for Economic
and Clinical Health (HITECH) Act in 2009 heralded new privacy and
security requirements and more onerous penalties and enforcement
of HIPAA.  HHS has issued several versions of rules to implement
the security breach, business associate, and penalty provisions. 
This presentation will explain how these provisions affect how
pharmacies must comply, the impact of HIPAA and HITECH on patient
counseling, and how lawyers must comply with privacy and security
requirements as business associates. 
Kevin N. Nicholson, RPh, JD, NACDS; Susan A. Buckna, JD, Shopko
Stores Operating Company (1.5 credit hours)
6:30 pm – 9:30 pm Reception/Dinner -  ASPL/NASPA
Saturday, November 17, 2012
7:00 am – 8:00 am Breakfast - ASPL/NASPA
8:00 am– 9:30am Legislative & Regulatory Update
This annual session will provide an overview of recently enacted and
proposed laws and regulations that affect pharmacy.  
Brian Gallagher, BS Pharm, JD, American Pharmacists Association 
(1.5 credit hours)
 9:30 am – 10:30 am Ethical Decision Making for Attorneys
and Pharmacists
As professional both pharmacists and lawyers face times in their day
when ethical decisions need to be made.  In this program we will
explore selected parts of the legal Code of Professional Responsibility
and the Pharmacist Code of Ethics as principles that can be applied
to ethical decision making for both professions.  We will explore
teaching from Aristotle to General Patton and others to construct
an ethical decision making algorism. 
Kenneth R. Baker, RPh, JD, Ken Baker Consulting  (1 credit hour)
10:30 am – 10:45 am Break
10:45 am – 12:15 pm Veterinary and Human Compounding
Since the Food and Drug Administration Modernization Act (FDAMA)
of 1997 was passed, confusion has reigned over the legal parameters
for pharmacy compounding.  Contradictory court decisions, FDA’s
interpretation and enforcement of laws, and dissonance between
FDAMA and FDA guidelines, have all contributed to the confusion.
Similar factors have confounded compounders of veterinary
products. This presentation will explain the laws, regulations, and
court decisions affecting human and veterinary compounding so
attendees can better understand the law and enforcement in these
areas.  Held in cooperation with the Food and Drug Law Institute.
Mark S. Brown, JD, King and Spalding LLP (1.5 credit hours)
1:30 pm– 4:00 pm Pharmacy Law Educators
This years pharmacy law education session will include a presentation
and workshop component.  The presentation will discuss active
learning in and outside of the classroom while the workshops will
include groups developing potential exercises and assignments that
can be used for pharmacy law professors.Sunday, November 18, 2012
7:00 am – 8:00 am Breakfast ASPL
8:00 am– 9:00 am Trends in the Regulation of Automation
This session will examine the types of automation available and
application in patient care settings.  The speakers will review select
states’ regulation of automation, including an examination of the five
W’s – Who can utilize automation, What medications may be stored,
Why automation is used, Where automation is permitted, and When
automation can be used; as well as potential federal Anti-Kickback
Statute, Stark Law, and DEA issues. 
Anne M. O’Brien, JD; Edward D. Rickert, BPharm, RPh, JD, Krieg
DeVault (1 credit hour)
9:00 am – 10:00 am Drug Manufacturer Coupon Co-Pay
Programs: Legal, Policy and Business Considerations
As drug manufacturers face rigorous formulary reviews for their
products, stern generic and brand competition, and loss of
exclusivity, the advancement of coupon co-pay programs have given
them a new and forceful tool in their armamentarium to increase
market share and drive profit.  The presentation will review the legal,
policy, and business aspects of Drug Manufacturer Coupon Co-Pay
Programs and assess the value for the relevant stakeholders.
Matthew Seamon,  PharmD, JD,  Association Professor Nova
Southeastern University College of Pharmacy, Of Counsel Fuerst Ittlmen
(1 credit hour)
10:00 am – 10:15 am Break
10:15 am – 11:15 am Medication Therapy Management:
Nuts, Bolts, and Legal Considerations
Medicare Part D requires prescription drug programs to provide
Medication Therapy Management (MTM) for Medicare beneficiaries. 
This presentation will discuss the requirements for MTM, how
pharmacists carry out MTM programs, recent changes in the Part
D regulations governing MTM, the legal requirements and risks of
MTM as this type of monitoring and intervention spreads to the
private sector. 
Doug Burgoyne, PharmD, RPh, VRx Pharmacy Services (1 credit
hour)
11:15 am – 12:15 pm Challenges to Compliance in Current
Regulatory Framework
As the regulatory environment becomes more complex, pharmacies
are more frequently being investigated by administrative agencies.  
This program will discuss the ten most common compliance
issues that are being faced by pharmacies before state boards of
pharmacy, state controlled substance authorities, the Food and
Drug Administration, and the Drug Enforcement Administration.
It will also provide a framework for conducting self-audits of
pharmacy operations practices and strategies for responding to
agency investigations.    
Laura Carpenter, RPh, JD, LLM, Carpenter Law Firm PC; Michael
Simko, JD, Walgreens (1 credit hour)


 Register Today at www.aspl.org

Tuesday, August 14, 2012

Seminar on How to Survive a DEA Inspection for Compounding Controlled Substances

How to Survive a DEA Inspection Series: Compounding Controlled Substances
Published by International Academy of Compounding Pharmacists and Texas Pharmacy Association 
Summary
Part Four of a Four-Part Series. 

The responsibilities to enforced federal laws and regulations on the compounding of controlled substances by a pharmacy are placed on the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion). 

Since the focus of any DEA compliance inspection is record-keeping, a compounding pharmacy will need to be prepared for that unannounced inspection that will focus on the purpose for compounding medications containing controlled substances and records required by DEA to be maintained by the pharmacy. 

Attendees will familiarize themselves with the types of actions taken by DEA Diversion personnel at a compounding pharmacy. The focus of any compounding pharmacy is whether the pharmacy is compounding for a specific patient or group of patients needing a medication or the manufacturing of a controlled substance medication. 


Learning Objectives: 
At the conclusion of this program, the pharmacist and technician attendee will be able to:
  • Identify the authority of Drug Enforcement Administration (DEA) Office of Diversion Control (Diversion) personnel to conduct an unannounced inspection at a compounding pharmacy and records that will be inspected or copied by their personnel.
  • Discuss administrative or civil actions taken by DEA for failure of a pharmacy to maintain compounding records for Schedules II through V prescriptions filled or compounded by the pharmacy.
  • Identify DEA record-keeping violations pertaining to: Inventory of Controlled Substances, Batch Records, Power of Attorney forms and other records required to be maintained by the compounding pharmacy.
  • Discuss the failure of specific DEA Diversion offices to understand the difference between anticipatory compounding versus manufacturing and how a compounding pharmacy can handle such issue when DEA enters the pharmacy.
For more information, click here.

Monday, August 13, 2012

Contemporary Compounding CE


July 20-23, 2012 and September 14-16, 2012 - 1.7 CEUs

Compounded medications often play an extremely important role in the quality of patient care and prescribers have become increasingly aware of the benefits that customized medications offer. The pharmacist and pharmacy technician must have a strong foundation on how to prepare these products. Technology has provided the equipment and techniques necessary to compound effectively and accurately. To prepare participants to meet the needs of patients, we have designed a program that will provide the pharmacist and technician the knowledge and skills to prepare the highest quality of compounded medications and services.

For more information click here.

Men in Black: How to Respond to Federal, State, And Administrative Inspections, Warrants, and Requests for Records


2012 APA District 8 Meeting in Scottsboro on Tuesday, September 18th 

2012 District Meetings CPE Program

Pharmacy Law
Men in Black: How to Respond to Federal, State, And Administrative Inspections, Warrants, and Requests for Records
ACPE# 178-000-12-022-L03-P/T
Target Audience: Pharmacists and Pharmacy Technicians
Activity Type: Knowledge-Based
This program is approved for 1.0 hours general CPE.

Pharmacist and Technician Objectives: At the conclusion of the program, successful participants should be able to:
1. Define the term “administrative inspection warrant.”
2. Define the term “search warrant.”
3. Identify the federal, state and/or administrative agency that can legally request and inspection, warrant or request for records.
4. Identify professional and legal responsibility when presented with an administrative inspection warrant, search warrant or request for records.

Current Issues in Alabama Pharmacy - 2012ACPE# 178-000-12-023-L04-P/T
Target Audience: Pharmacists and Pharmacy Technicians
Activity Type: Knowledge-Based
This program is approved for 1.0 hours general CPE.

Pharmacist and Technician Objectives:
At the conclusion of the program, successful participants should be able to:
(1) Describe current health care initiatives involving
pharmacy in Alabama.
(2) Discuss state pharmacy legislative and regulatory issues.
(3) Discuss federal legislative and regulatory issues.

Alabama APA District 9 Meeting


2012 APA District 9 Meeting

Monday, September 17, 2012 (6:30 PM - 9:00 PM)

Schedule

Tuesday Sep 04

6:30–7:00pm
Registration/Dinner
7:00–8:00pm
How to Respond to Federal, State & Administrative Inspections, Warrants & Requests for Records
8:00–9:00pm
Current Issues in Alabama Pharmacy

For more information, click here.